Blood pressure measurements during treadmill exercise testing and the risk for the future development of atrial fibrillation.
Exercise stress testing
atrial fibrillation
blood pressure
cardiovascular disease
Journal
Hypertension research : official journal of the Japanese Society of Hypertension
ISSN: 1348-4214
Titre abrégé: Hypertens Res
Pays: England
ID NLM: 9307690
Informations de publication
Date de publication:
09 2022
09 2022
Historique:
received:
03
12
2021
accepted:
22
03
2022
revised:
11
02
2022
pubmed:
22
4
2022
medline:
19
8
2022
entrez:
21
4
2022
Statut:
ppublish
Résumé
Hypertension is a well-established risk factor for the onset and progression of atrial fibrillation (AF). Blood pressure (BP) measurements during routine exercise stress testing (EST) may identify subjects at increased risk for developing AF. We performed a retrospective analysis of treadmill EST carried out using the Bruce protocol in patients aged ≥40 years without a history of AF (n = 17,617; 42% women). BP was measured at rest, peak exercise, and 2-min recovery and analyzed for its association with the risk for developing AF. During a mean follow-up of 7 years, AF was documented in 4.5% of the patients. The incidence rate of AF per 1000 person-years increased with the rise in CHA
Identifiants
pubmed: 35444293
doi: 10.1038/s41440-022-00920-5
pii: 10.1038/s41440-022-00920-5
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1496-1504Informations de copyright
© 2022. The Author(s), under exclusive licence to The Japanese Society of Hypertension.
Références
Peters NS, Schilling RJ, Kanagaratnam P, Markides V. Atrial fibrillation: strategies to control, combat, and cure. Lancet. 2002;359:593–603.
doi: 10.1016/S0140-6736(02)07748-6
Chung MK, Refaat M, Shen WK, Kutyifa V, Cha YM, Di Biase L, et al. ACC Electrophysiology Section Leadership Council. Atrial Fibrillation: JACC Council Perspectives. J Am Coll Cardiol. 2020;75:1689–713.
doi: 10.1016/j.jacc.2020.02.025
Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, et al. ESC Scientific Document Group, 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42:373–498.
doi: 10.1093/eurheartj/ehaa612
Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010;137:263–72.
doi: 10.1378/chest.09-1584
Saliba W, Gronich N, Barnett-Griness O, Rennert G. Usefulness of CHADS2 and CHA
doi: 10.1016/j.amjmed.2016.02.029
Hu WS, Lin CL. Comparison of CHA
doi: 10.1016/j.atherosclerosis.2017.10.007
Verdecchia P, Angeli F, Reboldi G. Hypertension and atrial fibrillation: doubts and certainties from basic and clinical studies. Circ Res. 2018;122:352–68.
doi: 10.1161/CIRCRESAHA.117.311402
Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006;367:1747–57.
doi: 10.1016/S0140-6736(06)68770-9
Dzeshka MS, Shantsila A, Shantsila E, Lip GYH. Atrial fibrillation and hypertension. Hypertension. 2017;70:854–61.
doi: 10.1161/HYPERTENSIONAHA.117.08934
Schultz MG, Otahal P, Cleland VJ, Blizzard L, Marwick TH, Sharman JE. Exercise-induced hypertension, cardiovascular events, and mortality in patients undergoing exercise stress testing: a systematic review and meta-analysis. Am J Hypertens. 2013;26:357–66.
doi: 10.1093/ajh/hps053
Zafrir B, Aker A, Asaf Y, Saliba W. Blood pressure response during treadmill exercise testing and the risk for future cardiovascular events and new-onset hypertension. J Hypertens. 2022;40:143–52.
doi: 10.1097/HJH.0000000000002991
Bettoni M, Zimmermann M. Autonomic tone variations before the onset of paroxysmal atrial fibrillation. Circulation. 2002;105:2753–9.
doi: 10.1161/01.CIR.0000018443.44005.D8
Zimmermann M, Kalusche D. Fluctuation in autonomic tone is a major determinant of sustained atrial arrhythmias in patients with focal ectopy originating from the pulmonary veins. J Cardiovasc Electrophysiol. 2001;12:285–91.
doi: 10.1046/j.1540-8167.2001.00285.x
O’Neal WT, Qureshi WT, Blaha MJ, Ehrman JK, Brawner CA, Nasir K, et al. Relation of risk of atrial fibrillation with systolic blood pressure response during exercise stress testing (from the henry ford exercise testing project). Am J Cardiol. 2015;116:1858–62.
doi: 10.1016/j.amjcard.2015.09.024
Reges O, Weinberg H, Hoshen M, Greenland P, Rayyan-Assi H, Avgil Tsadok M, et al. Combining inpatient and outpatient data for diagnosis of non-valvular atrial fibrillation using electronic health records: a validation study. Clin Epidemiol. 2020;12:477–83.
doi: 10.2147/CLEP.S230677
Fletcher GF, Ades PA, Kligfield P, Arena R, Balady GJ, Bittner VA, et al. Exercise standards for testing and training: a scientific statement from the American Heart Association. Circulation. 2013;128:873–934.
doi: 10.1161/CIR.0b013e31829b5b44
Barlow PA, Otahal P, Schultz MG, Shing CM, Sharman JE. Low exercise blood pressure and risk of cardiovascular events and all-cause mortality: systematic review and meta-analysis. Atherosclerosis 2014;237:13e22.
doi: 10.1016/j.atherosclerosis.2014.08.029
Kim D, Ha JW. Hypertensive response to exercise: mechanisms and clinical implication. Clin Hypertens. 2016;22:17.
doi: 10.1186/s40885-016-0052-y
Tzemos N, Lim PO, Mackenzie IS, MacDonald TM. Exaggerated exercise blood pressure response and future cardiovascular disease. J Clin Hypertens (Greenwich). 2015;17:837–44.
doi: 10.1111/jch.12629
Tucker NR, Ellinor PT. Emerging directions in the genetics of atrial fibrillation. Circ Res. 2014;114:1469–82.
doi: 10.1161/CIRCRESAHA.114.302225
Ehrlich JR, Hohnloser SH, Nattel S. Role of angiotensin system and effects of its inhibition in atrial fibrillation: clinical and experimental evidence. Eur Heart J. 2006;27:512–8.
doi: 10.1093/eurheartj/ehi668
Cardin S, Li D, Thorin-Trescases N, Leung TK, Thorin E, Nattel S. Evolution of the atrial fibrillation substrate in experimental congestive heart failure: angiotensin-dependent and independent pathways. Cardiovasc Res. 2003;60:315–25.
doi: 10.1016/j.cardiores.2003.08.014
Boldt A, Wetzel U, Weigl J, Garbade J, Lauschke J, Hindricks G, et al. Expression of angiotensin II receptors in human left and right atrial tissue in atrial fibrillation with and without underlying mitral valve disease. J Am Coll Cardiol. 2003;42:1785–92.
doi: 10.1016/j.jacc.2003.07.014
Dixen U, Ravn L, Soeby-Rasmussen C, Paulsen AW, Parner J, Frandsen E, et al. Raised plasma aldosterone and natriuretic peptides in atrial fibrillation. Cardiology 2007;108:35–9.
doi: 10.1159/000095671
Savelieva I, Kakouros N, Kourliouros A, Camm AJ. Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention. Europace. 2011;13:308–28.
doi: 10.1093/europace/eur002
Verdecchia P, Mazzotta G, AngeliF, Reboldi G. Above Which Blood Pressure Level Does the Risk of Atrial Fibrillation Increase? Hypertension. 2012;59:184–5.
doi: 10.1161/HYPERTENSIONAHA.111.187260
Pierdomenico SD, Ianni U, De Rosa M, Coccina F. Different measures of blood pressure and incident atrial fibrillation. J Hypertens. 2021;39:38–41.
doi: 10.1097/HJH.0000000000002645
Qureshi WT, Alirhayim Z, Blaha MJ, Juraschek SP, Keteyian SJ, Brawner CA, et al. Cardiorespiratory fitness and risk of incident atrial fibrillation: results from the Henry Ford Exercise Testing (FIT) project. Circulation. 2015;131:1827–34.
doi: 10.1161/CIRCULATIONAHA.114.014833
Conen D, Tedrow UB, Koplan BA, Glynn RJ, Buring JE, Albert CM. Influence of systolic and diastolic blood pressure on the risk of incident atrial fibrillation in women. Circulation. 2009;119:2146–52.
doi: 10.1161/CIRCULATIONAHA.108.830042
Grundvold I, Skretteberg PT, Liestøl K, Erikssen G, Kjeldsen SE, Arnesen H, et al. Upper normal blood pressures predict incident atrial fibrillation in healthy middle-aged men: a 35-year follow-up study. Hypertension. 2012;59:198–204.
doi: 10.1161/HYPERTENSIONAHA.111.179713
O’Neal WT, Soliman EZ, Qureshi W, Alonso A, Heckbert SR, Herrington D. Sustained pre-hypertensive blood pressure and incident atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis. J Am Soc Hypertens. 2015;9:191–6.
doi: 10.1016/j.jash.2015.01.001
Mitchell GF. Arterial stiffness and hypertension. Hypertension. 2014;64:13–8.
doi: 10.1161/HYPERTENSIONAHA.114.00921
Morseth B, Graff-Iversen S, Jacobsen BK, Jørgensen L, Nyrnes A, Thelle DS, et al. Physical activity, resting heart rate, and atrial fibrillation: the Tromsø Study. Eur Heart J. 2016;37:2307–13.
doi: 10.1093/eurheartj/ehw059
Trivedi SJ, Claessen G, Stefani L, Flannery MD, Brown P, Janssens K, et al. Differing mechanisms of atrial fibrillation in athletes and non-athletes: alterations in atrial structure and function. Eur Heart J Cardiovasc Imaging. 2020;21:1374–83.
doi: 10.1093/ehjci/jeaa183
Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. ESC Scientific Document Group. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39:3021–104.
doi: 10.1093/eurheartj/ehy339